Trails Edge Capital Partners, LP
Top Portfolio Positions
26 positions ·
$450,063,852 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| PCVX |
Vaxcyte, Inc.
Healthcare
|
662,470 | $38,496,131 | 8.55% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
640,000 | $37,216,000 | 8.27% | |
| DFTX |
Definium Therapeutics, Inc.
Healthcare
|
1,738,110 | $32,850,279 | 7.30% | |
| LBRX |
Lb Pharmaceuticals Inc
Healthcare
|
1,319,362 | $32,535,466 | 7.23% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
333,312 | $30,791,362 | 6.84% | |
| IKT |
Inhibikase Therapeutics, Inc.
Healthcare
|
16,114,690 | $27,072,678 | 6.02% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
1,743,220 | $27,019,910 | 6.00% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
245,000 | $23,826,250 | 5.29% | |
| RCUS |
Arcus Biosciences, Inc.
Healthcare
|
1,047,935 | $22,635,396 | 5.03% | |
| IMCR |
Immunocore Holdings plc
Healthcare
|
682,597 | $20,580,299 | 4.57% |
Portfolio Trend
2 quarters · across all stocks
Holdings in NGNE
Shares Held
Position Value (USD)
3 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,780,985 | 782,787 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $16,171,000 | 785,000 | Shares | Sole | 2026-02-17 | |
| 2025-12-08 | $16,163,150 | 785,000 | Shares | Sole | 2025-12-15 | |
| No 13F history on record for this holder in this stock. | ||||||